Iron-Overload Cardiomyopathy: Evidence for a Free Radical– Mediated Mechanism of Injury and Dysfunction in a Murine Model

Biological Research For Nursing

Volumn 2, Issue 1, 2000, Pages 49-59

  Bartfay, Wally J ^a   Bartfay, Emma ^b  

^a School of Nursing at Queens University   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

cardiomyopathy; free radicals; glutathione peroxidase; heart failure; Iron; murine model; ventricular function

Indexed keywords

FREE RADICAL; GLUTATHIONE PEROXIDASE; IRON; IRON DEXTRAN;

ANIMAL; ARTICLE; BODY BURDEN; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DBA MOUSE; DISEASE MODEL; DOSE RESPONSE; HEART MUSCLE; HEMODYNAMICS; IRON OVERLOAD; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RANDOMIZATION; RESTRICTIVE CARDIOMYOPATHY;

ANIMALS; BODY BURDEN; CARDIOMYOPATHY, RESTRICTIVE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICALS; GLUTATHIONE PEROXIDASE; HEMODYNAMIC PROCESSES; IRON; IRON OVERLOAD; IRON-DEXTRAN COMPLEX; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MYOCARDIUM; RANDOM ALLOCATION;

EID: 0034232355     PISSN: 10998004     EISSN: None     Source Type: Journal    
DOI: 10.1177/109980040000200106     Document Type: Article

References (57)

1. Al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GJ, Hoffbrand AV. 1992. Serum non-transferrin-bound iron in beta-thalassemia major patients treated with desferrioxamine and L1. Br J Haematol 82: 431-436.
2. Ball A, Sole MJ. 1998. Oxidative stress and the pathogenesis of heart failure. Cardiol Clin 16: 665-675.
3. Bartfay WJ, Butany J, Sole MJ, Hou D, Bartfay E, Liu PP. 1999. A biochemical, histochemical, and electron microscopic study on the effects of iron-loading in heart of mice. Cardiovasc Pathol 43(4):892-900.
4. Bartfay WJ, Dawood FD, Wen WH, Lehotay DC, Hou D, Bartfay E, Luo XP, Backx PH, Liu PP. 1999. Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. Cardiovasc Res 43: 892-900.
5. Bartfay WJ, Hou D, Brittenham GM, Bartfay E, Sole MJ, Lehotay D, Liu PP. 1998. The synergistic effects of vitamin E and selenium in iron-loaded mouse hearts. Can J Cardiol 14: 937-941.
6. Bartfay WJ, Lehotay DC, Sher GD, Bartfay E, Tyler B, Luo XP, Liu PP. 1999. Comparison of cytotoxic aldehyde generation in beta-thalassemia patients chelated with deferoxamine or deferiprone (L1) versus no chelation. Hematology 4: 67-76.
7. Bothwell TH, MacPhail AP. 1998. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol 35: 55-71.
8. Bottomley SS. 1998. Secondary iron overload disorders. Semin Hematol 35: 77-86.
9. Brooks WW, Apstein CS. 1996. Effect of treppe on isovolumic function in the isolated blood-perfused mouse heart. J Mol Cell Cardiol 28: 1817-1822.
10. Burkitt MJ, Mason RP. 1991. Direct evidence for in vivo hydroxyl radical generation in experimental iron overload: an ESR spin-trapping investigation. Proc Natl Acad Sci U S A 88: 8440-8444.
11. Byler RM, Sherman NA, Wallner JS, Horwitz LD. 1994. Hydrogen peroxide cytotoxicity is iron dependent. Am J Physiol 35: H121-H127.
12. Cheeseman KH. 1993. Mechanisms and effects of lipid peroxidation. Mol Aspects Med 14: 191-197.
13. Doring HJ, Dehnert H. 1987. The isolated perfused heart according to Langendorff. West Germany: Biomesstechnik-Verlag. Esterbauer H. 1993. Cytotoxicity and genotoxicity of lipid-peroxidation products. Am J Clin Nutr 57: 779S-786S.
14. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z. 1996. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399-408.
15. Fleet JC. 1996. Discovery of the hemochromatosis gene will require rethinking the regulation of iron metabolism. Nutr Rev 54: 285-292.
16. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. 1989. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. J Biol Chem 264: 4417-4422.
17. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. 1993. Comparison of normal hypodynamic and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol 34: H1401-H1410.
18. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. 1985. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 68: 463-467.
19. Halliwell B. 1994. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344: 721-724.
20. Halliwell B. 1997. Antioxidants and human disease: a general introduction. Nutr Rev 55: S44-S52.
21. Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T. 1994. Most free radical injury is iron-mediated. It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12:289-303. Hollan SR. 1997. Transfusion-associated iron-overload. Curr Opin Hematol 4: 436-441.
22. Kaplan J, Jordan I, Sturrock A. 1991. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 266: 2997-3004.
23. Kontophiorghes GJ, Weinberg ED. 1995. Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches. Blood Rev 9: 33-45.
24. Kukreja RC, Hess ML. 1992. The oxygen free radical system: from equations through membrane/protein interactions to cardiovascular injury and protection. Cardiovasc Res 26: 641-655.
25. Lawrence D, Rosenthal EA. 1999. Iron-mediated cardiovascular injury. Vasc Med 4: 93-99.
26. Lesnefsky EJ. 1994. Tissue iron-overload and mechanisms of iron-catalyzed oxidative injury. Adv Exp Med Biol 366: 129-146.
27. Lewis SE, Johnson FM, Skow LC, Barnett LB, Popp RA. 1985. A mutation in the beta-globin gene detected among the progeny of a female mouse treated with ethylnitrosaurea. Proc Natl Acad Sci U S A 82: 5829-5831.
28. Link G, Athias P, Grynberg A, Hershko C, Pinson A. 1996. Iron-loading modifies beta-adrenergic responsiveness in cultured ventricular myocytes. Cardioscience 2: 185-188.
29. Link G, Pinson A, Hershko C. 1985. Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med 106: 147-153.
30. Liu P, Henkleman RM, Joshi J, Hardy P, Butany J, Iwanochko M, Clauberg M, Dhar M, Waien S, Olivieri N. 1996. Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia cardiac iron-overload model. Can J Cardiol 12: 155-164.
31. Liu P, Olivieri N. 1994. Iron-overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs ther 8: 101-110.
32. Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, D-Arpa D, D'Anna R, Bongiorno A. 1996. Oxidative stress and antioxidant status in beta-Thalassemia major: iron-overload and depletion of lipid-soluble antioxidants. Blood 88: 3608-3614.
33. Loebstein R, Lehotay DC, Bartfay WJ, Tyler B, Sher G. 1998. Diabetic nephropathy in hypertransfused patients with beta-thalassemia: the role of oxidative stress. Diabet Care 21(8):1306-1309.
34. Luo XP, Yazdanpanah M, Bhooi N, Lehotay DC. 1995. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal Biochem 228: 294-298.
35. Lynch SR. 1995. Iron-overload: Prevalence and impact on health. Nutr Rev 53: 255-260.
36. Machlin LJ, Bendich A. 1987. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 41: 441-445.
37. McCord JM. 1996. Effects of positive iron status at a cellular level. Nutr Rev 54: 85-88.
38. McMaster D, Bell N, Anderson P, Hg-Love A. 1990. Automated measurements of two indicators of human selenium status and applicability to population study. Clin Chem 36: 211-216.
39. Michiel C, Raes M, Toussaint O, Remacle J. 1994. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17: 235-248.
40. Montgomery DC. 1991. Design and analysis of experiments. 3rd ed. Toronto: John Wiley.
41. Myers ML, Farhangkhoee P, Karmazyn M. 1998. Hydrogen peroxide induced impairment of postischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642. Cardiovasc Res 40: 290-296.
42. Ng WA, Robbins J, Subramaniam A, Grupp IL. 1991. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res 68: 1742-1750.
43. Olfert ED, Cross BM, McWilliams AA. 1993. Canadian council on animal care: guide to the use of experimental animals. 2nd ed. Ottawa, Ontario: Bradda.
44. Omara FO, Blakeley BR, Wanjala LS. 1993. Hepatoxicity associated with dietary iron-overload in mice. Hum Exp Toxicol 12: 463-467.
45. Parkes JG, Hussain RA, Olivieri NF, Templeton DM. 1993. Effect of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. J Lab Clin Med 122: 36-47.
46. Pucheu S, Coudray C, Tressalet N, Favier A, de Leiris J. 1993. Effect of iron-overload in the isolated ischemic and reperfused rat heart. Cardiovasc Drugs ther 7: 701-711.
47. Randell EW, Parkes JG, Olivieri NF, Templeton DM. 1994. Uptake of nontransferrin-bound iron by both reductive and nonreductive processes is mediated by intracellular iron. J Biol Chem 269: 16046-16053.
48. Samuni A, Winkelsberg D, Pinson A, Hahn SM, Mitchell JB, Russo A. 1991. Nitroxide stable radicals protects beating cardiomyocytes against oxidative damage. J Clin Invest 87: 526-530.
49. Singal PK, Kraper N, Palace V, Kumar D. 1998. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 40: 426-432.
50. Skow JC, Burkhart BA, Johnson EM, Popp RA, Popp DM, Goldberg SZ, Anderson WF, Barnett LB, Lewis SE. 1983. A mouse model for beta-thalassemia. Cell 34: 1043-1052.
51. Stohs SJ, Bagchi D. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18: 321-336.
52. Tsushima RG, Wilkenden AD, Bouchard RA, Oudit GY, Liu PP, Backx P. 1999. Modulation of iron uptake in heart by L-type Ca 2+channel modifiers: possible implications of iron overload. Circ Res 11: 1302-1309.
53. UK Thalassaemia Society. 1993. All you need to know about the beta-thalassemia trait. London: Author.
54. Wagstaff M, Peters SW, Jones BM, Jacobs A. 1986. Free-iron and iron toxicity in iron overload. Br J Haematol 67: 566-567.
55. Winegar BD, Kelly R, Larsen JB. 1991. Block of current through single calcium channels by Fe, Co and Ni. J Gen Physiol 97: 351-367.
56. Yazdanpanah M, Luo XP, Lau R, Greenberg M, Fisher LJ, Lehotay DC. 1997. Cytotoxic aldehydes as possible markers for childhood cancer. Free Radic Biol Med 23: 870-878.
57. Young IS, Trouton TG, Torney JJ, McMaster D, Callender M, Trimble ER. 1994. Antioxidant status and lipid peroxidation in hereditary hemochromatosis. Free Radic Biol Med 16: 393-397.